Atypical antipsychotic dosing: the effect of smoking and caffeine.
about
Pharmacokinetics of olanzapine long-acting injection: the clinical perspective.Depression and Cognitive Impairment Are Associated with Low Education and Literacy Status and Smoking but Not Caffeine Consumption in Urban African Americans and White Adults.Smoking cessation in patients with psychiatric disordersMetabolic drug interactions with newer antipsychotics: a comparative review.Treatment of tobacco dependence in mental health and addictive disorders.Pharmacogenetics in psychiatry: are we ready for widespread clinical use?A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophreniaEffects of smoking cues on caffeine urges in heavy smokers and caffeine consumers with and without schizophrenia.The practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approach.A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients.Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics.A Reasonable Alternative to Clozapine in the Chronically Relapsing Smoking Patient? A Retrospective Analysis.Sialorrhea and aspiration pneumonia: a case study.Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.Urine testing for antipsychotics: a pilot trial for a method to determine detection levels.Relationship between tobacco and cannabis use status in outpatients with schizophrenia.
P2860
Q34293855-A2EAC589-9426-4646-A5AE-9BDCAA3E9698Q35149343-642CAEA6-02C2-422C-A345-ECB32457C738Q36474143-9E4EB2EC-59A0-4777-92E2-59A398FED833Q36703845-BCE98C0E-5129-496C-977C-48972CDA6BB4Q36783506-011B8830-2628-485C-B110-46498DE0E8F0Q37076472-58C3B7AC-7F51-4B2F-837C-A743A954AC30Q37218646-7D7B665F-61EB-415A-ADAA-46D97AA0F2F6Q37394848-1A62EE9F-71A9-4770-8761-93B6E2A6D1AAQ38247122-C4551C68-AB26-4112-9403-8625F79571A4Q38630825-60DF5811-23D6-4A97-A12F-B890BAB28290Q38734067-5344C6D8-E334-4561-8530-4626D4BA7D16Q39121457-99BE475E-E8B3-47FD-9457-7CB2D05D4B3AQ42130700-59A2F033-460C-4A4F-A0FC-B8C1C190B511Q47120840-8226910D-262A-4E9B-88CC-33A10952DA83Q48082169-65AC76D7-B203-4FE2-AA09-7B5D1FAE373CQ50624456-46DD527E-8DFA-4E28-B36B-98172D1D81D2
P2860
Atypical antipsychotic dosing: the effect of smoking and caffeine.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Atypical antipsychotic dosing: the effect of smoking and caffeine.
@ast
Atypical antipsychotic dosing: the effect of smoking and caffeine.
@en
type
label
Atypical antipsychotic dosing: the effect of smoking and caffeine.
@ast
Atypical antipsychotic dosing: the effect of smoking and caffeine.
@en
prefLabel
Atypical antipsychotic dosing: the effect of smoking and caffeine.
@ast
Atypical antipsychotic dosing: the effect of smoking and caffeine.
@en
P356
P1433
P1476
Atypical antipsychotic dosing: the effect of smoking and caffeine.
@en
P2093
Jose de Leon
P304
P356
10.1176/APPI.PS.55.5.491
P577
2004-05-01T00:00:00Z